Ironwood Pharmaceuticals, Inc. (IRWD) financial statements (2023 and earlier)

Company profile

Business Address 100 SUMMER STREET, SUITE 2300
BOSTON, MA 02110
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments620363177173221305439
Cash and cash equivalents62036317717312654261
Short-term investments    96251178
Restricted cash and investments1211   
Receivables11412211781826555
Inventory, net of allowances, customer advances and progress billings  1 11 
Inventory  1 11 
Derivative instruments and hedges, assets1      
Other undisclosed current assets991111796
Total current assets:745496307266312380500
Noncurrent Assets
Operating lease, right-of-use asset151718
Property, plant and equipment891217172121
Long-term investments and receivables242333    
Accounts and financing receivable, after allowance for credit loss242333    
Intangible assets, net (including goodwill)  11161167 
Goodwill  1111 
Intangible assets, net (excluding goodwill)    160166 
Derivative instruments and hedges 13314110813386
Restricted cash and investments0016 89
Deferred income tax assets333  
Other noncurrent assets1100113
Other undisclosed noncurrent assets    7  
Total noncurrent assets:382639666294330119
TOTAL ASSETS:1,127559403332606710619
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22183460545632
Accounts payable1141816189
Accrued liabilities331115133823
Employee-related liabilities1713192624  
Taxes payable0      
Interest and dividends payable02011  
Deferred revenue  1
Debt117 1484628
Deferred rent credit   0
Derivative instruments and hedges, liabilities1      
Restructuring reserve01103   
Due to related parties  2  00
Business combination, contingent consideration, liability   0014 
Deferred revenue and credits0813
Other undisclosed current liabilities22338774
Total current liabilities:1623241120669176
Noncurrent Liabilities
Long-term debt and lease obligation356451430366 132133
Long-term debt, excluding current maturities337430408366 132133
Capital lease obligations0 00
Operating lease, liability182022
Liabilities, other than long-term debt414254313418594
Deferred revenue and credits518
Deferred rent credit   6
Other liabilities42135810
Business combination, contingent consideration, liability    3163 
Derivative instruments and hedges, liabilities 1224349211375
Total noncurrent liabilities:359464455409134318227
Total liabilities:521497496528200409303
Stockholders' equity
Stockholders' equity attributable to parent, including:60663(93)(196)106795
Common stock000    
Additional paid in capital1,5431,5291,4791,3951,3191,2581,205
Accumulated other comprehensive loss    (0)(0)(0)
Accumulated deficit(938)(1,466)(1,572)(1,591)(1,309)(1,192)(1,110)
Other undisclosed stockholders' equity attributable to parent   0000
Total stockholders' equity:60663(93)(196)106795
Other undisclosed liabilities and equity    396234221
TOTAL LIABILITIES AND EQUITY:1,127559403332606710619

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues414390428347298274150
Cost of revenue (3)(24)(33)(19)(2)(0)
Cost of goods and services sold (3)(24)(33) (0)(18)
Gross profit:414386405314279272150
Operating expenses(182)(243)(291)(584)(388)(314)(234)
Other undisclosed operating income (loss)0 73131(10)(18)
Operating income (loss):232143120(239)(77)(52)(102)
Nonoperating expense(32)(34)(61)(43)(40)(30)(41)
Investment income, nonoperating(0)(5)6(6)(1)9(9)
Interest and debt expense(31)(29)(31)(38)(2)(39)(31)
Income (loss) from continuing operations before equity method investments, income taxes:1707928(320)(119)(121)(174)
Other undisclosed income from continuing operations before income taxes3129     
Income (loss) from continuing operations before income taxes:20110928(320)(119)(121)(174)
Income tax expense (benefit)328(3)     
Other undisclosed income from continuing operations  31    
Income (loss) from continuing operations:52810659(320)(119)(121)(174)
Loss from discontinued operations  (37)    
Income (loss) before gain (loss) on sale of properties:52810622(320)(119)(121)(174)
Other undisclosed net income   382  
Net income (loss) attributable to parent:52810622(282)(117)(121)(174)
Other undisclosed net income available to common stockholders, basic     3931
Net income (loss) available to common stockholders, diluted:52810622(282)(117)(82)(143)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):52810622(282)(117)(121)(174)
Comprehensive income (loss):52810622(282)(117)(121)(174)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   0(0)3931
Comprehensive income (loss), net of tax, attributable to parent:52810622(282)(117)(82)(143)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: